{"doi":"10.1038/s41591-025-03572-3","title":"Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial","abstract":"Janus kinase (JAK) inhibitors provide limited depth and durability of response in myelofibrosis. We evaluated pelabresib-a bromodomain and extraterminal domain (BET) inhibitor-plus ruxolitinib (a JAK inhibitor) compared with placebo plus ruxolitinib as first-line therapy. In this phase 3 study (MANIFEST-2), JAK inhibitor-naive patients with myelofibrosis were randomized 1:1 to pelabresib 125 mg once daily (QD; 50-175 mg QD permitted) for 14 days followed by a 7-day break (21-day cycle), or to placebo in combination with ruxolitinib 10 or 15 mg twice daily (BID; 5 mg QD-25 mg BID permitted). Primary endpoint was reduction in spleen volume of ≥35% from baseline at week 24. Key secondary endpoints were absolute change in total symptom score (TSS) and TSS50 response (≥50% reduction in TSS from baseline at week 24). The primary endpoint was met in 65.9% of patients randomized to pelabresib-ruxolitinib (n = 214) versus 35.2% to placebo-ruxolitinib (n = 216) (difference, 30.4%; 95% confidence interval (CI), 21.6, 39.3; P < 0.001). Absolute change in TSS was -15.99 versus -14.05 (difference, -1.94; 95% CI, -3.92, 0.04; P = 0.0545) and TSS50 was achieved in 52.3% versus 46.3% (difference, 6.0%; 95 CI, -3.5, 15.5) with pelabresib-ruxolitinib versus placebo-ruxolitinib. Exploratory analyses of proinflammatory cytokine amounts and bone marrow morphology showed greater improvement with the combination. Thrombocytopenia and anemia were the most common treatment-emergent adverse events, occurring in 52.8% (13.2% grade ≥3) versus 37.4% (6.1% grade ≥3) and 44.8% (23.1% grade ≥3) versus 55.1% (36.5% grade ≥3), respectively. Pelabresib in combination with ruxolitinib is well tolerated, improves signs of underlying myelofibrosis pathobiology and provides substantial clinical benefit over standard-of-care JAK inhibitor monotherapy. ClinicalTrials.gov identifier: NCT04603495 .","journal":"Nature Medicine","year":2025,"id":509249,"datarank":0.6642666741250457,"base_score":3.713572066704308,"endowment":3.713572066704308,"self_citation_contribution":0.5570358100056463,"citation_network_contribution":0.1072308641193994,"self_endowment_contribution":0.5570358100056463,"citer_contribution":0.1072308641193994,"corpus_percentile":null,"corpus_rank":null,"citation_count":40,"citer_count":30,"citers_with_citation_signal":8,"citers_with_endowment":8,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9533,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT04603495"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1363125,"name":"Sebastian Grosicki","orcid":"0000-0003-2644-1050","position":1,"is_corresponding":false},{"id":1363980,"name":"Dominik Chraniuk","orcid":null,"position":2,"is_corresponding":false},{"id":1052919,"name":"Elisabetta Abruzzese","orcid":"0000-0001-5228-6491","position":3,"is_corresponding":false},{"id":232848,"name":"Prithviraj Bose","orcid":"0000-0002-4343-5712","position":4,"is_corresponding":false},{"id":284118,"name":"Aaron T. Gerds","orcid":"0000-0002-3422-1309","position":5,"is_corresponding":false},{"id":628534,"name":"Alessandro M. Vannucchi","orcid":"0000-0001-5755-0730","position":6,"is_corresponding":false},{"id":1363126,"name":"Francesca Palandri","orcid":"0000-0001-8367-5668","position":7,"is_corresponding":false},{"id":1363127,"name":"Sung‐Eun Lee","orcid":"0000-0002-9810-2050","position":8,"is_corresponding":false},{"id":284120,"name":"Vikas Gupta","orcid":"0000-0002-1419-8607","position":9,"is_corresponding":false},{"id":1363128,"name":"Alessandro Lucchesi","orcid":"0000-0002-0624-5311","position":10,"is_corresponding":false},{"id":628540,"name":"Stephen T. Oh","orcid":"0000-0002-8564-5400","position":11,"is_corresponding":false},{"id":284122,"name":"Andrew Kuykendall","orcid":"0000-0002-9040-7415","position":12,"is_corresponding":false},{"id":361392,"name":"Andrea Patriarca","orcid":"0000-0003-4415-2906","position":13,"is_corresponding":false},{"id":1363129,"name":"Alberto Álvarez‐Larrán","orcid":"0000-0001-6387-4619","position":14,"is_corresponding":false},{"id":94310,"name":"Ruben A. Mesa","orcid":"0000-0001-5880-7972","position":15,"is_corresponding":false},{"id":438286,"name":"Jean‐Jacques Kiladjian","orcid":"0000-0002-8121-438X","position":16,"is_corresponding":false},{"id":284124,"name":"Moshe Talpaz","orcid":"0000-0003-3361-3981","position":17,"is_corresponding":false},{"id":366486,"name":"Joseph M. Scandura","orcid":"0000-0002-9525-143X","position":18,"is_corresponding":false},{"id":1363981,"name":"David Lavie","orcid":null,"position":19,"is_corresponding":false},{"id":879543,"name":"Morgan Harris","orcid":"0000-0003-3821-5931","position":20,"is_corresponding":false},{"id":1363982,"name":"Sarah-Katharina Kays","orcid":null,"position":21,"is_corresponding":false},{"id":1363130,"name":"Qing Li","orcid":"0000-0002-8632-9637","position":22,"is_corresponding":false},{"id":1363983,"name":"Rainer Boxhammer","orcid":null,"position":23,"is_corresponding":false},{"id":1093864,"name":"Barbara Brown","orcid":null,"position":24,"is_corresponding":false},{"id":1363984,"name":"Anna-Maria Jegg","orcid":null,"position":25,"is_corresponding":false},{"id":289786,"name":"Claire Harrison","orcid":"0000-0002-3212-920X","position":26,"is_corresponding":false},{"id":266853,"name":"John Mascarenhas","orcid":"0000-0002-8400-0483","position":27,"is_corresponding":false},{"id":259770,"name":"Raajit K. Rampal","orcid":"0000-0002-0355-6368","position":0,"is_corresponding":true}],"reference_count":31,"raw_metadata":null,"created_at":"2026-07-19T02:47:24.513904Z","pmid":"40065169","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}